Finding 957122 (2023-006)

Material Weakness Repeat Finding
Requirement
M
Questioned Costs
-
Year
2023
Accepted
2024-03-15

AI Summary

  • Core Issue: The Organization failed to monitor subrecipients properly due to a lack of written policies and procedures, misclassifying them as contractors instead of subrecipients.
  • Impacted Requirements: Noncompliance with 2 CFR § 200.331 and § 200.332, which mandates specific monitoring and agreement requirements for subrecipients.
  • Recommended Follow-Up: Establish written policies for subrecipient monitoring and create procedures to correctly identify funding recipients, ensuring compliance with federal regulations.

Finding Text

2023-006 – Subrecipient Monitoring Federal Program: Refugee and Entrant Assistance Program Federal Agency: U.S. Department of Health and Human Services Assistance Listing Number: 93.566 Repeat of Prior Finding: No Type of Finding: Noncompliance and Material Weakness in Internal Controls Over Compliance Criteria According to 2 CFR § 200.331, a pass-through entity must make case-by-case determinations whether each agreement it makes for the disbursement of Federal program funds casts the party receiving the funds in the role of a subrecipient or a contractor. If determined to be a subrecipient, the entity must adhere to the provisions in 2 CFR § 200.332 which require passthrough entities to perform certain subrecipient monitoring procedures. These procedures include providing the subrecipient necessary award information so that the federal award is used in accordance with federal regulations, evaluating risks of noncompliance of subrecipients, implementing monitoring procedures based upon identified risks, and, if applicable, obtaining a copy of the subrecipients’ annual audit, and taking appropriate action on deficiencies detected through the audits, as well as other requirements. Additionally, the nonfederal entity must establish and maintain effective internal controls over the federal award to provide reasonable assurance that the non-federal entity is managing the award in compliance with federal regulations. Further, according to 2 CFR § 200.331(a), specific information must be explicitly included in agreements with subrecipients that includes but is not limited to providing the Assistance Listing number, whether funding is COVID related, and that the subrecipient is responsible for compliance with 2 CFR § 200 including Subpart F, if applicable. Condition and Context The Organization did not have written policies and procedures in place to ensure that subrecipients are monitored and managed in accordance with Uniform Guidance 2 CFR § 200.332. The Organization did not have procedures in place to properly identify the party receiving funds from the Organization as a subrecipient and therefore assumed that the recipient was a subcontractor. As the proper determination was not made, there were no written agreements between the Organization and the subrecipients. Cause The Organization was unaware of these requirements and determined the receiver of the funds to be a subcontractor. Accordingly, there was no monitoring performed by the Organization over the subrecipient. Effect or Potential Effect Without a proper written grant agreement, subrecipients may be unaware that their award is subject to federal compliance requirements. The Organization could award federal funds to a high-risk entity and fail to adjust the methods of monitoring accordingly. Questioned Costs None noted. Recommendations We recommend that the Organization establish a written policy to monitor subrecipients and develop procedures for determining if the party receiving the funds is considered to be a subrecipient or a contractor. Further, we recommend maintaining a template to be in compliance with applicable regulations, ensuring that the subrecipient is aware of their responsibilities to adhere to federal regulations. Views of Responsible Officials and Planned Corrective Actions Management agrees with the finding and recommendations. See the attached corrective action plan

Categories

Subrecipient Monitoring Matching / Level of Effort / Earmarking Material Weakness

Other Findings in this Audit

  • 380648 2023-005
    Material Weakness
  • 380649 2023-005
    Material Weakness
  • 380650 2023-005
    Material Weakness
  • 380651 2023-005
    Material Weakness
  • 380652 2023-005
    Material Weakness
  • 380653 2023-005
    Material Weakness
  • 380654 2023-005
    Material Weakness
  • 380655 2023-005
    Material Weakness
  • 380656 2023-005
    Material Weakness
  • 380657 2023-005
    Material Weakness
  • 380658 2023-005
    Material Weakness
  • 380659 2023-005
    Material Weakness
  • 380660 2023-005
    Material Weakness
  • 380661 2023-005
    Material Weakness
  • 380662 2023-005
    Material Weakness
  • 380663 2023-005
    Material Weakness
  • 380664 2023-005
    Material Weakness
  • 380665 2023-005
    Material Weakness
  • 380666 2023-006
    Material Weakness Repeat
  • 380667 2023-006
    Material Weakness Repeat
  • 380668 2023-006
    Material Weakness Repeat
  • 380669 2023-006
    Material Weakness Repeat
  • 380670 2023-006
    Material Weakness Repeat
  • 380671 2023-006
    Material Weakness Repeat
  • 380672 2023-006
    Material Weakness Repeat
  • 380673 2023-006
    Material Weakness Repeat
  • 380674 2023-006
    Material Weakness Repeat
  • 380675 2023-006
    Material Weakness Repeat
  • 380676 2023-006
    Material Weakness Repeat
  • 380677 2023-006
    Material Weakness Repeat
  • 380678 2023-006
    Material Weakness Repeat
  • 380679 2023-006
    Material Weakness Repeat
  • 380680 2023-006
    Material Weakness Repeat
  • 380681 2023-006
    Material Weakness Repeat
  • 380682 2023-006
    Material Weakness Repeat
  • 380683 2023-006
    Material Weakness Repeat
  • 380684 2023-007
    Significant Deficiency
  • 380685 2023-007
    Significant Deficiency
  • 380686 2023-007
    Significant Deficiency
  • 380687 2023-007
    Significant Deficiency
  • 380688 2023-007
    Significant Deficiency
  • 380689 2023-007
    Significant Deficiency
  • 380690 2023-007
    Significant Deficiency
  • 380691 2023-007
    Significant Deficiency
  • 380692 2023-007
    Significant Deficiency
  • 380693 2023-007
    Significant Deficiency
  • 380694 2023-007
    Significant Deficiency
  • 380695 2023-007
    Significant Deficiency
  • 380696 2023-007
    Significant Deficiency
  • 380697 2023-007
    Significant Deficiency
  • 380698 2023-007
    Significant Deficiency
  • 380699 2023-007
    Significant Deficiency
  • 380700 2023-007
    Significant Deficiency
  • 380701 2023-007
    Significant Deficiency
  • 380702 2023-008
    Significant Deficiency
  • 380703 2023-008
    Significant Deficiency
  • 380704 2023-008
    Significant Deficiency
  • 380705 2023-008
    Significant Deficiency
  • 380706 2023-008
    Significant Deficiency
  • 380707 2023-008
    Significant Deficiency
  • 380708 2023-008
    Significant Deficiency
  • 380709 2023-008
    Significant Deficiency
  • 380710 2023-008
    Significant Deficiency
  • 380711 2023-008
    Significant Deficiency
  • 380712 2023-008
    Significant Deficiency
  • 380713 2023-008
    Significant Deficiency
  • 380714 2023-008
    Significant Deficiency
  • 380715 2023-008
    Significant Deficiency
  • 380716 2023-008
    Significant Deficiency
  • 380717 2023-008
    Significant Deficiency
  • 380718 2023-008
    Significant Deficiency
  • 380719 2023-008
    Significant Deficiency
  • 957090 2023-005
    Material Weakness
  • 957091 2023-005
    Material Weakness
  • 957092 2023-005
    Material Weakness
  • 957093 2023-005
    Material Weakness
  • 957094 2023-005
    Material Weakness
  • 957095 2023-005
    Material Weakness
  • 957096 2023-005
    Material Weakness
  • 957097 2023-005
    Material Weakness
  • 957098 2023-005
    Material Weakness
  • 957099 2023-005
    Material Weakness
  • 957100 2023-005
    Material Weakness
  • 957101 2023-005
    Material Weakness
  • 957102 2023-005
    Material Weakness
  • 957103 2023-005
    Material Weakness
  • 957104 2023-005
    Material Weakness
  • 957105 2023-005
    Material Weakness
  • 957106 2023-005
    Material Weakness
  • 957107 2023-005
    Material Weakness
  • 957108 2023-006
    Material Weakness Repeat
  • 957109 2023-006
    Material Weakness Repeat
  • 957110 2023-006
    Material Weakness Repeat
  • 957111 2023-006
    Material Weakness Repeat
  • 957112 2023-006
    Material Weakness Repeat
  • 957113 2023-006
    Material Weakness Repeat
  • 957114 2023-006
    Material Weakness Repeat
  • 957115 2023-006
    Material Weakness Repeat
  • 957116 2023-006
    Material Weakness Repeat
  • 957117 2023-006
    Material Weakness Repeat
  • 957118 2023-006
    Material Weakness Repeat
  • 957119 2023-006
    Material Weakness Repeat
  • 957120 2023-006
    Material Weakness Repeat
  • 957121 2023-006
    Material Weakness Repeat
  • 957123 2023-006
    Material Weakness Repeat
  • 957124 2023-006
    Material Weakness Repeat
  • 957125 2023-006
    Material Weakness Repeat
  • 957126 2023-007
    Significant Deficiency
  • 957127 2023-007
    Significant Deficiency
  • 957128 2023-007
    Significant Deficiency
  • 957129 2023-007
    Significant Deficiency
  • 957130 2023-007
    Significant Deficiency
  • 957131 2023-007
    Significant Deficiency
  • 957132 2023-007
    Significant Deficiency
  • 957133 2023-007
    Significant Deficiency
  • 957134 2023-007
    Significant Deficiency
  • 957135 2023-007
    Significant Deficiency
  • 957136 2023-007
    Significant Deficiency
  • 957137 2023-007
    Significant Deficiency
  • 957138 2023-007
    Significant Deficiency
  • 957139 2023-007
    Significant Deficiency
  • 957140 2023-007
    Significant Deficiency
  • 957141 2023-007
    Significant Deficiency
  • 957142 2023-007
    Significant Deficiency
  • 957143 2023-007
    Significant Deficiency
  • 957144 2023-008
    Significant Deficiency
  • 957145 2023-008
    Significant Deficiency
  • 957146 2023-008
    Significant Deficiency
  • 957147 2023-008
    Significant Deficiency
  • 957148 2023-008
    Significant Deficiency
  • 957149 2023-008
    Significant Deficiency
  • 957150 2023-008
    Significant Deficiency
  • 957151 2023-008
    Significant Deficiency
  • 957152 2023-008
    Significant Deficiency
  • 957153 2023-008
    Significant Deficiency
  • 957154 2023-008
    Significant Deficiency
  • 957155 2023-008
    Significant Deficiency
  • 957156 2023-008
    Significant Deficiency
  • 957157 2023-008
    Significant Deficiency
  • 957158 2023-008
    Significant Deficiency
  • 957159 2023-008
    Significant Deficiency
  • 957160 2023-008
    Significant Deficiency
  • 957161 2023-008
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
97.010 Citizenship Education and Training $158,085
14.228 Community Development Block Grants/state's Program and Non-Entitlement Grants in Hawaii $154,642
93.268 Immunization Cooperative Agreements $46,266
93.566 Refugee and Entrant Assistance_state Administered Programs $10,824
21.027 Coronavirus State and Local Fiscal Recovery Funds $6,428
14.218 Community Development Block Grants/entitlement Grants $4,300